Data Doesn’t Show Clear Link Between Weight Loss Drugs and Suicidal Ideation: FDA

Published on January 12, 2024

There is no evidence weight loss drugs like Wegovy and Ozempic are tied to suicidal ideation, the U.S. Food and Drug Administration said in its preliminary review released Thursday, Jan. 11. “We determined that the information in these reports did not demonstrate a clear relationship with the use of GLP-1 RAs,” the FDA wrote. However, the FDA stopped short of giving the medications a completely clean bill of health. While the data so far doesn’t demonstrate a link, the agency said it couldn’t definitively rule out a small risk either. Adverse Event Reports Drive FDA Probe The FDA’s investigation follows months of adverse event reports linking suicidal ideation to GLP-1 agonists, a class of medications used to treat type 2 diabetes and obesity....